Divis Laboratories, a pharmaceutical ingredients and intermediates company, said Saturday the board of directors recommend issue of bonus equity shares in the ratio of 1:1 that is one equity share for every one equity share. The bonus issue is subject to approval by the members of the company. The record date will be determined at later date.

Recently the company posted a consolidated rise of 17.84% to Rs 2.31 billion in the quarter ended March 2015 as against Rs 1.96 billion during the previous quarter ended March 2014.

Total income rose 9.56% to Rs 8.32 billion in the quarter ended March 2015 as against Rs 7.59 billion during the previous quarter last year.

Shares of the company gained Rs 111.55, or 5.66%, to trade at Rs 2,082.80. The total volume of shares traded was 48,056 at the BSE (1.08 p.m., Monday).